Prelude Therapeutics shares owned by Morgan Stanley
Quarter-by-quarter ownership of Prelude Therapeutics (PRLD) shares owned by Morgan Stanley
from 13F filings
Historical chart of Morgan Stanley investment in Prelude Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Prelude Therapeutics held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Prelude Therapeutics by Morgan Stanley
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-06-30 | $230k | 284k | 0.81 |
| 2024-12-31 | $466k | 365k | 1.28 |
| 2024-09-30 | $670k | 324k | 2.07 |
| 2024-06-30 | $1.1M | 287k | 3.81 |
| 2024-03-31 | $1.4M | 296k | 4.74 |
| 2023-12-31 | $1.3M | 299k | 4.27 |
| 2023-09-30 | $755k | 245k | 3.09 |
| 2023-06-30 | $879k | 195k | 4.50 |
| 2022-12-31 | $543k | 90k | 6.04 |
| 2022-06-30 | $1.9M | 481k | 4.02 |
| 2022-03-31 | $3.5M | 547k | 6.35 |
| 2021-06-30 | $0 | 132k | 0.00 |
| 2020-12-31 | $1.9M | 27k | 71.52 |
| 2020-09-30 | $396k | 13k | 30.10 |